India to Tanzania: Chlorambucil Export Trade Route
India has recorded 26 verified shipments of Chlorambucil exported to Tanzania, representing a combined trade value of $5.9K USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $226 USD. The leading Indian exporter is S. Himatlal Healthcare LLP, which accounts for 39% of total export value with 8 shipments worth $2.3K USD. On the buying side, TO THE ORDER OF is the largest importer in Tanzania with $3.2K USD in purchases. The top 3 suppliers — S. Himatlal Healthcare LLP, RMPL PHARMA LLP, S HIMATLAL HEALTHCARE LLP — together control 77% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Tanzania Chlorambucil corridor is one of India's established pharmaceutical export routes, with 26 shipments documented worth a combined $5.9K USD. The route is dominated by S. Himatlal Healthcare LLP, which alone accounts for roughly 39% of all export value, reflecting the consolidated nature of India's chlorambucil manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $226 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (60%) and air (40%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April-June, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 34.0%, placing it at rank #15 among India's top chlorambucil export destinations globally.
On the import side, key buyers of Indian chlorambucil in Tanzania include TO THE ORDER OF, TO THE ORDER OF INVOICE, TO THE ORDER OF INVOICE RAISED TO and 5 others. TO THE ORDER OF is the single largest importer with 14 shipments valued at $3.2K USD.
